Oncosoft Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 42

Employees

  • Latest Deal Type
  • Series B2

  • Latest Deal Amount
  • $10.4M

  • Investors
  • 15

Oncosoft General Information

Description

Operator of a medical technology company intended to develop artificial intelligence software for radiation oncology. The company's application utilizes deep learning to automate tasks in radiation therapy, such as treatment site detection and organ contour generation, enabling radiation oncologists to improve treatment accuracy, and the overall efficiency of radiation therapy.

Contact Information

Website
www.oncosoft.io
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 37, Myeongmul-gil
  • Seodaemun-gu
  • Seoul
  • South Korea
+82
Primary Industry
Decision/Risk Analysis
Other Industries
Outcome Management (Healthcare)
Other Healthcare Technology Systems
Vertical(s)
Artificial Intelligence & Machine Learning, Life Sciences, Oncology
Corporate Office
  • 37, Myeongmul-gil
  • Seodaemun-gu
  • Seoul
  • South Korea
+82

Oncosoft Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oncosoft Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series B2) 02-Jul-2026 $10.4M Completed Generating Revenue
7. Later Stage VC (Series B) 01-Sep-2024 Completed Generating Revenue
6. Secondary Transaction - Private Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2023 Completed Generating Revenue
4. Early Stage VC (Series A) 21-Aug-2022 Completed Generating Revenue
3. Early Stage VC 01-Jun-2021 Completed Generating Revenue
2. Accelerator/Incubator 01-Oct-2020 $126K Completed Generating Revenue
1. Seed Round 31-Aug-2020 $126K $126K Completed Generating Revenue
To view Oncosoft’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Oncosoft Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a medical technology company intended to develop artificial intelligence software for radiation oncology. Th
Decision/Risk Analysis
Seoul, South Korea
42 As of 2026

Regina, Canada
 

Helsinki, Finland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Oncosoft Competitors (2)

One of Oncosoft’s 2 competitors is Limbus AI, a Private Equity-Backed company based in Regina, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Limbus AI Private Equity-Backed Regina, Canada
MVision (Healthcare Technology Systems) Venture Capital-Backed Helsinki, Finland
You’re viewing 2 of 2 competitors. Get the full list »

Oncosoft Patents

  • 19

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 10

    Pending

  • Expiring in next 12 mo

Oncosoft Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026212084-A1 Method for generating and segmenting synthetic medical image and apparatus for performing same Pending 01-Apr-2025
WO-2026197517-A1 Method and apparatus for assigning radiation room Pending 21-Mar-2025
WO-2026160584-A1 Method and apparatus for managing radiation therapy workflow Pending 24-Jan-2025
WO-2026155538-A1 Method and apparatus for managing radio pharmaceutical therapy data Pending 20-Jan-2025
WO-2025110865-A1 Method and apparatus for providing clinical decision support system Inactive 24-Nov-2023 G16H50/20
To view Oncosoft’s complete patent history, request access »

Oncosoft Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oncosoft Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Comes Investment Venture Capital Minority
Horizon Investment Venture Capital Minority
Korea Investment & Securities Asset Manager Minority
TimeWorks Investment Venture Capital Minority
Wanted Lab Partners (South Korea) Growth/Expansion Minority
You’re viewing 5 of 15 investors. Get the full list »

Ready to get started?

Request a free trial

Oncosoft FAQs

  • When was Oncosoft founded?

    Oncosoft was founded in 2019.

  • Where is Oncosoft headquartered?

    Oncosoft is headquartered in Seoul, South Korea.

  • What is the size of Oncosoft?

    Oncosoft has 42 total employees.

  • What industry is Oncosoft in?

    Oncosoft’s primary industry is Decision/Risk Analysis.

  • Is Oncosoft a private or public company?

    Oncosoft is a Private company.

  • What is Oncosoft’s current revenue?

    The current revenue for Oncosoft is .

  • How much funding has Oncosoft raised over time?

    Oncosoft has raised $21.8M.

  • Who are Oncosoft’s investors?

    Comes Investment, Horizon Investment, Korea Investment & Securities, TimeWorks Investment, and Wanted Lab Partners (South Korea) are 5 of 15 investors who have invested in Oncosoft.

  • Who are Oncosoft’s competitors?

    Limbus AI and MVision (Healthcare Technology Systems) are competitors of Oncosoft.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process